BCL2 and acute myeloid leukemia: It can combat versus mutant expressing factors in acute myeloid leukemia cells, namely FLT3-ITD (like in MV4-16 and Molm-18 cells), p53 silencing (like in shp53 Molm-18, and shp53 MV4-16), and overexpressing of Bcl2 protein (like in IPC-81-Bcl2).